Climb Bio, Inc.

NasdaqGM:CLYM 주식 보고서

시가총액: US$346.0m

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Climb Bio 관리

관리 기준 확인 1/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Aoife Brennan

최고 경영자

n/a

총 보상

CEO 급여 비율n/a
CEO 임기no data
CEO 소유권n/a
경영진 평균 재임 기간less than a year
이사회 평균 재임 기간4.5yrs

최근 관리 업데이트

Recent updates

Eliem Therapeutics: Recent Strategic Pipeline Restructuring

Sep 23

Eliem Therapeutics: Year End 2024 MN Data With Further Potential To Unlock Value

Jun 28

Here's Why We're Not Too Worried About Eliem Therapeutics' (NASDAQ:ELYM) Cash Burn Situation

Feb 01
Here's Why We're Not Too Worried About Eliem Therapeutics' (NASDAQ:ELYM) Cash Burn Situation

We Think Eliem Therapeutics (NASDAQ:ELYM) Needs To Drive Business Growth Carefully

Jun 24
We Think Eliem Therapeutics (NASDAQ:ELYM) Needs To Drive Business Growth Carefully

We're Not Very Worried About Eliem Therapeutics' (NASDAQ:ELYM) Cash Burn Rate

Mar 08
We're Not Very Worried About Eliem Therapeutics' (NASDAQ:ELYM) Cash Burn Rate

We're Not Very Worried About Eliem Therapeutics' (NASDAQ:ELYM) Cash Burn Rate

Nov 18
We're Not Very Worried About Eliem Therapeutics' (NASDAQ:ELYM) Cash Burn Rate

Eliem Therapeutics GAAP EPS of -$0.56 misses by $0.09

Aug 15

Eliem to discontinue development of lead asset as mid-stage pain trial fails

Aug 02

SVB Leerink cuts PT on Eliem Therapeutics, reaffirms Outperform rating

Jul 11

CEO

Aoife Brennan (48 yo)

no data

테뉴어

Dr. Aoife M. Brennan, M.D. M.B., Ch B., BAO, MMSc, MRCPI, is CEO, President and Director at Climb Bio, Inc. (formerly known as Eliem Therapeutics, Inc.) Dr. Brennan serves as Director of Xilio Therapeutics...


리더십 팀

이름위치테뉴어보상소유권
Aoife Brennan
CEO, President & Directorno data데이터 없음데이터 없음
Brett Kaplan
COO & Principal Financial Officerless than a year데이터 없음데이터 없음
Emily Pimblett
Chief Accounting Officer1.7yrs데이터 없음0.011%
$ 39.0k
Jo Palmer-Phillips
Chief Development Officerno data데이터 없음데이터 없음
Nishi Rampal
Senior Vice President of Clinical Developmentless than a year데이터 없음데이터 없음

0.2yrs

평균 재임 기간

48yo

평균 연령

경험이 풍부한 관리: ELYM 의 관리팀은 경험 (평균 재직 기간 1.3 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.


이사회 구성원

이름위치테뉴어보상소유권
Aoife Brennan
CEO, President & Directorno data데이터 없음데이터 없음
Adam Rosenberg
Independent Director4yrsUS$77.16k0.27%
$ 919.0k
Liam Ratcliffe
Lead Independent Director5yrsUS$71.33k0%
$ 0
Simon Tate
Independent Director5.7yrsUS$22.52k0%
$ 0
Andrew Levin
Co-Founder & Chairman5.7yrsUS$87.91k0%
$ 0
Stephen Thomas
Directorless than a year데이터 없음0.15%
$ 536.2k
Judith Dunn
Independent Director3.7yrsUS$69.66k0%
$ 0

4.5yrs

평균 재임 기간

54yo

평균 연령

경험이 풍부한 이사회: ELYM 의 이사회경험(평균 재직 기간 4.7 년)으로 간주됩니다.